Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $1.8B |
| Sales growthchange from the year before | -1.2% |
| Gross marginshare of sales left after the direct cost of what it sells | 40.4% |
| Operating marginshare of sales left after running the business | 36.0% |
| Net marginshare of sales kept as profit | 16.5% |
| Free-cash-flow marginspare cash generated per $100 of sales | 17.0% |
| Return on invested capitalprofit made on each $100 put into the business | 10.9% |
| Return on equityprofit vs. shareholders' accounting value | 24.6% |
| Debt / equitydebt vs. shareholders' accounting value | 2.91 |
| Change in share countnegative = the company is buying back its shares | -13.1% |
3 insiders sold $992K on the open market.
| Deshaies Robert JosephCOO, Benefits | SoldJul 30 | 1,000 shat $184.95 · $185K |
| Drew Ann ElenaChief Risk and Compliance | SoldJul 27 | 3,400 shat $176.02 · $598K |
| Kimball JenniferChief Accounting Officer | SoldJul 27 | 1,183 shat $176.55 · $209K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy